FDA accepts BridgeBio NDA for encaleret to treat ADH1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. SPY
3. DFTX
4. AZN
5. NVDA
6. SRRK
7. SATL
8. LYNX
9. ENB
10. USO

Go back to FDA accepts BridgeBio NDA for encaleret to treat ADH1
(NASDAQ: BBIO) Delayed: 72.84 +0.40 (0.55%)
Previous Close $72.44    52 Week High $ 
Open $72.55    52 Week Low $ 
Day High $73.15    P/E N/A 
Day Low $72.28    EPS $ 
Volume 147,376